SK278918B6 - Farmaceutický prostriedok proti vysokému krvnému t - Google Patents

Farmaceutický prostriedok proti vysokému krvnému t Download PDF

Info

Publication number
SK278918B6
SK278918B6 SK2270-92A SK227092A SK278918B6 SK 278918 B6 SK278918 B6 SK 278918B6 SK 227092 A SK227092 A SK 227092A SK 278918 B6 SK278918 B6 SK 278918B6
Authority
SK
Slovakia
Prior art keywords
pharmaceutical composition
phenylpropylamino
ethoxycarbonyl
oxo
carboxylic acid
Prior art date
Application number
SK2270-92A
Other languages
English (en)
Slovak (sk)
Other versions
SK227092A3 (en
Inventor
Jean-Paul Clozel
Rita M�Ller
Wolfgang Osterrieder
Original Assignee
F. Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche Ag filed Critical F. Hoffmann-La Roche Ag
Publication of SK227092A3 publication Critical patent/SK227092A3/sk
Publication of SK278918B6 publication Critical patent/SK278918B6/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • External Artificial Organs (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK2270-92A 1991-07-23 1992-07-21 Farmaceutický prostriedok proti vysokému krvnému t SK278918B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH219191 1991-07-23

Publications (2)

Publication Number Publication Date
SK227092A3 SK227092A3 (en) 1996-02-07
SK278918B6 true SK278918B6 (sk) 1998-04-08

Family

ID=4228024

Family Applications (1)

Application Number Title Priority Date Filing Date
SK2270-92A SK278918B6 (sk) 1991-07-23 1992-07-21 Farmaceutický prostriedok proti vysokému krvnému t

Country Status (31)

Country Link
US (1) US5620975A (cs)
EP (1) EP0524512B1 (cs)
JP (1) JPH0680009B2 (cs)
KR (1) KR100260479B1 (cs)
CN (1) CN1040505C (cs)
AT (1) ATE260661T1 (cs)
AU (1) AU656207B2 (cs)
BG (1) BG60949B1 (cs)
BR (1) BR9202830A (cs)
CA (1) CA2074039C (cs)
CZ (1) CZ281691B6 (cs)
DE (1) DE59209993D1 (cs)
DK (1) DK0524512T3 (cs)
ES (1) ES2215160T3 (cs)
HR (1) HRP930953B1 (cs)
HU (1) HU214029B (cs)
IE (1) IE922378A1 (cs)
IL (1) IL102541A (cs)
IS (1) IS3887A (cs)
MX (1) MX9204212A (cs)
MY (1) MY118064A (cs)
NO (1) NO301047B1 (cs)
NZ (1) NZ243577A (cs)
PT (1) PT524512E (cs)
RO (1) RO110905B (cs)
RU (1) RU2084225C1 (cs)
SK (1) SK278918B6 (cs)
TW (1) TW216770B (cs)
UY (1) UY23449A1 (cs)
YU (2) YU72392A (cs)
ZA (1) ZA925322B (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE198551T1 (de) * 1993-07-15 2001-01-15 Hoffmann La Roche Pharmazeutische kombination, die einen hemmer des renin-angiotensin-systems und einen endothelin- antagonisten enthält
IL131816A (en) 1997-04-04 2003-06-24 Exxon Res & Engineering Compan Composite structures having high containment strength
CA2462913A1 (en) 2001-10-10 2003-04-17 Aryx Therapeutics Mibefradil-based compounds as calcium channel blockers useful in the treatment of hypertension and angina
US7687086B1 (en) 2003-02-28 2010-03-30 University Of Portland Method for obtaining taxanes
EP2537534B1 (en) 2011-06-22 2014-12-17 Hexal AG Esters of (1S,9S)-9-[[(1S)-1-carboxy-3-phenylpropyl]amino]octahydro-10-oxo-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid and their therapeutic use.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2128984B (en) * 1982-05-12 1985-05-22 Hoffmann La Roche Diaza-bicyclic compounds
DE3542794A1 (de) * 1985-12-04 1987-06-11 Bayer Ag Antihypertensives kombinationspraeparat
CA1319144C (en) * 1986-11-14 1993-06-15 Quirico Branca Tetrahydronaphthalene derivatives
FR2607004B1 (fr) * 1986-11-20 1990-06-01 Synthelabo Compositions pharmaceutiques contenant du diltiazem et un inhibiteur de l'enzyme de conversion de l'angiotensine
US5110813A (en) * 1987-09-15 1992-05-05 Alcoholism And Drug Addiction Research Foundation Reduction of voluntary alcohol consumption by treatment with angiotensin converting enzyme inhibitors
US4871731A (en) * 1987-10-07 1989-10-03 Marion Laboratories, Inc. Captopril and diltiazem composition and the like
KR940005408B1 (ko) * 1990-12-03 1994-06-18 만도기계 주식회사 파워 윈도우 모우터 회전자의 선단부 흔들림 측정장치

Also Published As

Publication number Publication date
CA2074039A1 (en) 1993-01-24
CN1040505C (zh) 1998-11-04
HRP930953B1 (en) 2003-06-30
MX9204212A (es) 1993-08-01
EP0524512A2 (de) 1993-01-27
IL102541A (en) 1995-12-08
HU9202367D0 (en) 1992-10-28
IS3887A (is) 1993-01-24
IL102541A0 (en) 1993-01-14
US5620975A (en) 1997-04-15
MY118064A (en) 2004-08-30
CA2074039C (en) 2004-11-02
AU656207B2 (en) 1995-01-27
KR100260479B1 (ko) 2000-07-01
NO922903L (no) 1993-01-25
JPH0680009B2 (ja) 1994-10-12
HUT62792A (en) 1993-06-28
BR9202830A (pt) 1993-03-23
YU49198B (sh) 2004-09-03
RO110905B (ro) 1996-05-30
AU2041692A (en) 1993-01-28
CN1068737A (zh) 1993-02-10
RU2084225C1 (ru) 1997-07-20
ES2215160T3 (es) 2004-10-01
KR930001910A (ko) 1993-02-22
BG60949B1 (bg) 1996-07-31
TW216770B (cs) 1993-12-01
NO922903D0 (no) 1992-07-22
YU72392A (sh) 1997-05-28
EP0524512A3 (en) 1993-09-01
NZ243577A (en) 1994-09-27
ZA925322B (en) 1993-03-31
NO301047B1 (no) 1997-09-08
ATE260661T1 (de) 2004-03-15
DE59209993D1 (de) 2004-04-08
DK0524512T3 (da) 2004-07-05
HU214029B (en) 1997-12-29
CZ227092A3 (en) 1993-02-17
UY23449A1 (es) 1993-01-21
HRP930953A2 (en) 1995-10-31
IE922378A1 (en) 1993-01-27
EP0524512B1 (de) 2004-03-03
JPH05194217A (ja) 1993-08-03
CZ281691B6 (cs) 1996-12-11
PT524512E (pt) 2004-07-30
SK227092A3 (en) 1996-02-07

Similar Documents

Publication Publication Date Title
FI92904B (fi) Menetelmä suun kautta annettavaksi tarkoitetun, aktiiviyhdistettä kontrolloidusti vapauttavan farmaseuttisen formulaation valmistamiseksi
HU199302B (en) Process for producing synergic pharmaceutical compositions having hypotensive activity
CZ226095A3 (en) The use of anticonvulsive agents for preparing medicaments intended for treating neuronal degeneration caused by aids
SK278918B6 (sk) Farmaceutický prostriedok proti vysokému krvnému t
EP0471388B1 (de) Mittel zur Behandlung der Herzinsuffizienz
DE19815411A1 (de) Thermogenese stimulierend wirksame Arzneimittel
JPH0148245B2 (cs)
DE19849737A1 (de) Kombinationsmittel zur Behandlung entzündlicher Darmerkrankungen
GB2083749A (en) Drug combination comprising ambroxol and an antibiotic for the treatment of infectious diseases of the respiratory tract
US3360434A (en) Method for reducing blood pressure with phenylalanine derivatives
US4391809A (en) Methods for treating psoriasis
US3904758A (en) Method of increasing wakefulness
EP0334164B1 (de) Antihypertensives Kombinationspräparat
DE3627613A1 (de) Pharmazeutische zubereitung
EP0576452A1 (de) Erzeugnisse, enthaltend verapamil und trandolapril.
KR970006083B1 (ko) 위장질환 치료용 의약 조성물
US4499106A (en) Lipolytic composition and method of treating obesity
US3622671A (en) Substituted 3-hydrazino pyridazines as hypotensives
JPS6110510A (ja) 免疫抑制作用を有する新規な医薬組成物
EP0260527A2 (de) Neue synergistische Kombination bestehend aus einem Phosphodiesterase-Hemmer und einem Tromboxan-A2-Antagonisten und deren Verwendung bzw. Herstellung
IE43955B1 (en) Pharmaceutical composition and dosage units thereof
HU200941B (en) Process for producing pharmaceutical compositions comprising n-carboxyalkyldipeptide derivatives as active ingredient and suitable for treating coronary diseases and diseases of cerabral vascular system
AU2440400A (en) Use of moxonidine for postmyocardial infarction treatment
AU2003244430A1 (en) Combination preparation of the sodium-hydrogen exchange inhibitor cariporide with ace inhibitors for preventing heart failure and other age-related dysfunctions of organs, age- related diseases and for prolonging lifespan
MXPA00000522A (en) Treatment and prevention of cardiac disorders using selective serotonin re-uptake inhibitors (ssri)